Xcerra Corp. (NASDAQ:XCRA)’s share price fell 2.6% during trading on Monday . The stock traded as low as $5.96 and last traded at $5.99, with a volume of 136,474 shares trading hands. The stock had previously closed at $6.15.

Several research firms have commented on XCRA. B. Riley reiterated a “buy” rating and issued a $8.25 price objective on shares of Xcerra Corp. in a report on Tuesday, June 7th. Needham & Company LLC reiterated a “hold” rating on shares of Xcerra Corp. in a report on Tuesday, June 7th. DA Davidson reiterated a “buy” rating and issued a $10.00 price objective on shares of Xcerra Corp. in a report on Monday. Finally, Zacks Investment Research downgraded shares of Xcerra Corp. from a “hold” rating to a “sell” rating in a report on Wednesday, August 10th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the stock. Xcerra Corp. has an average rating of “Hold” and a consensus price target of $8.19.

The stock’s 50 day moving average price is $5.98 and its 200 day moving average price is $6.00. The firm has a market capitalization of $317.40 million and a P/E ratio of 27.97.

In related news, VP Pascal Ronde sold 30,000 shares of the stock in a transaction on Thursday, June 9th. The stock was sold at an average price of $6.63, for a total value of $198,900.00. Following the transaction, the vice president now directly owns 221,250 shares in the company, valued at approximately $1,466,887.50. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Xcerra Corporation, formerly LTX-Credence Corporation, is engaged in providing test and handling capital equipment, interface products, test fixtures and related services to the semiconductor and electronics manufacturing industries. The Company operates through six segments: Semiconductor Test, Semiconductor Handlers, Contactors, Printed Circuit Board (PCB) Test, Probes/Pins and Fixtures.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.